Biodexa Pharmaceuticals plc American Depositary Shs

BDRX XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.5M

Short interest (Jul 15)

1.1%

Net Short (Jul 27 ): -0.4%

Borrow Fee

165.53%

↓ 20.2%

Available Shares

70K

↓ 39.0%

Price Chart

Company Overview

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Company Info

Exchange: NASDAQ

CIK: 0001643918

Asset Type: ADRC

Market Data

Market Cap: $1,491,708

Employees: 11

Status: Active

Short Interest

Current Borrow Fee 165.53%

Range: 165.53% - 189.05%

Available Shares 70K

Range: 35K - 65K

Recent Changes

Fee Change: ↑ 6.9%

Available Change: ↑ 92.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime